Tag: Canada
-
Trial Shows Broad Coronavirus Immune Response
Initial results from a clinical trial show an experimental vaccine produces immune responses in healthy adults against Covid-19 variants and a range of other coronaviruses.
-
NIH Challenge Seeks Early Alzheimer’s Indicators with A.I.
A new crowdsourced competition seeks more robust early indicators of Alzheimer’s disease and related dementias using analytics powered by artificial intelligence.
-
Streamlined Gene Therapy Delivery Process Demonstrated
A group of academic and industry researchers exhibited in lab cells and mice a more direct delivery technique that could make gene therapies more accessible and inexpensive.
-
Bio-Friendly Plant Nutrient Delivery Patent Awarded
A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent.
-
Safer Forms of Psilocybin Assessed in Preclinical Study
A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects.
-
$15M Alternative Chicken, Fish Challenge Finalists Named
An international challenge competition seeking sustainable but realistic alternatives to natural chicken and fish protein named its six finalist teams.
-
Computational Drug Discovery Company Acquires A.I. Businesses
Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise.
-
Trial Shows Plant-Based Drug Helps Reduce Vaping
First results of a clinical trial show a drug derived from plants to aid in smoking cessation helps cut the use of e-cigarettes among non-smokers of burning tobacco.
-
Trial to Test Low-Dose Psilocybin for Mental Distress
A developer of mental health therapies from psychedelic compounds says it received FDA clearance for a clinical trial testing low doses of psilocybin.
-
Light-Activated Treatment Kills Covid-19 Nasal Viruses
Clinical trial findings show a light-activated disinfectant process kills SARS-CoV-2 viruses in the nose causing Covid-19 infections without harming nasal tissue.